The FY2025 (Nov) proxy of Nurix Therapeutics names 21 peer companies for pay. Pay versus performance data of Nurix Therapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Nov) proxy
| 1. Arcellx Inc. | Not disclosed | Not disclosed |
| 10. Intellia Therapeutics Inc. | Not disclosed | Not disclosed |
| 11. Iteos Therapeutics Inc. | Not disclosed | Not disclosed |
| 12. Kura Oncology Inc. | Not disclosed | Not disclosed |
| 13. Kymera Therapeutics Inc. | Not disclosed | Not disclosed |
| 14. Monte Rosa Therapeutics Inc. | Not disclosed | Not disclosed |
| 15. ORIC Pharmaceuticals Inc. | Not disclosed | Not disclosed |
| 16. Recursion Pharmaceuticals Inc. | Not disclosed | Not disclosed |
| 17. Relay Therapeutics Inc. | Not disclosed | Not disclosed |
| 18. Replimune Group Inc. | Not disclosed | Not disclosed |
| 19. Sutro Biopharma Inc. | Not disclosed | Not disclosed |
| 2. Arcus Biosciences, Inc. | Not disclosed | Not disclosed |
| 20. Tango Therapeutics Inc. | Not disclosed | Not disclosed |
| 21. Zentalis Pharmaceuticals Inc. | Not disclosed | Not disclosed |
| 3. Arvinas, Inc. | Not disclosed | Not disclosed |
| 4. C4 Therapeutics, Inc. | Not disclosed | Not disclosed |
| 5. Celldex Therapeutics, Inc. | Not disclosed | Not disclosed |
| 6. Cullinan Therapeutics, Inc. | Not disclosed | Not disclosed |
| 7. Erasca, Inc. | Not disclosed | Not disclosed |
| 8. IDEAYA Biosciences, Inc. | Not disclosed | Not disclosed |
| 9. IGM Biosciences Inc. | Not disclosed | Not disclosed |
21 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.